Last call: put your bladder cancer knowledge to the test. Don’t delay: this activity expires on October 23!
APPs: level up your bladder cancer management game . Test your knowledge of treatment approaches in our game show–style CE activity. Rack up points, earn credit, and sharpen your management skills! With @BladderCancerUS and Colleen Tetzlaff @Onc_PA_Mom
RedMedEd retweeted
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer?
This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
RedMedEd retweeted
Replying to @HadidiSamer
Strange to have approval before publication. Hope we will have a publication ASAP.
RedMedEd retweeted
Free @RedMedEd CE opportunity! How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?
Learn from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
APPs: level up your bladder cancer management game . Test your knowledge of treatment approaches in our game show–style CE activity. Rack up points, earn credit, and sharpen your management skills! With @BladderCancerUS and Colleen Tetzlaff @Onc_PA_Mom
Clinical Callout, our CME-accredited activity on developments in bladder cancer patient care, provides downloadable practice tools—including several developed by our partner @BladderCancerUS —to help you optimize care for your bladder cancer patients.
CME/CE roundtable: muscle-invasive bladder cancer care. Review important developments in treatment with @BladderCancerUS, @ERPlimackMD, @siadaneshmand, and Colleen Tetzlaff @Onc_PA_Mom
Click on the link below to view catalog and earn CME education.redmeded.com/s/cat…
Quick, case-based myeloma CME—available now. Make sure your approach to relapsed myeloma is keeping pace with recent advances in our newest Ace the Case activities with @SurbhiSidanaMD #mmsm
RedMedEd retweeted
How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer?
Continuing education from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
@RedMedEd
RedMedEd retweeted
⚠️ CDC estimates that nearly 500,000 American suffer from Alpha-gal syndrome, with emerging evidence suggesting that number is potentially in the millions.
“We intend to bring the same urgency, innovation, and scientific rigor to Alpha-gal syndrome that we are to Lyme disease.” —@SecKennedy
RedMedEd retweeted
Replying to @VincentRK
This is what happens with the work all the folks here have done
RedMedEd retweeted
Think you’re up to date on the AEs associated with bladder cancer immunotherapy?
Find out in this game-based CME activity developed for APPs, nurses, and other HCPs who treat bladder cancer. @RedMedEd
















